Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 21, Number 9—September 2015
Emerging Infections Program
Emerging Infections Program

Tracking Pertussis and Evaluating Control Measures through Enhanced Pertussis Surveillance, Emerging Infections Program, United States

Tami H. SkoffComments to Author , Joan Baumbach, and Paul R. Cieslak
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (T.H. Skoff); New Mexico Department of Health, Santa Fe, New Mexico, USA (J. Baumbach); Oregon Health Authority, Portland, Oregon, USA (P.R. Cieslak)

Main Article


Completeness of pertussis surveillance data collected from the NNDSS and EPS, United States, 2011–2012*

Characteristic Complete, %†
Difference, %
Race 76 91 15
Ethnicity 72 93 11
Any cough 79 100 21
Paroxysms 78 100 22
Whoop 74 97 23
Post-tussive vomiting 75 99 24
Primary symptoms known§ 72 96 24
Cough onset date 66 100 34
Duration of cough 71 100 29
Hospitalized 73 99 26
≥1 vaccine date and type, age range 3 mo–7 y 71 99 28

*Data were obtained from Kamiya et al. (7). NNDSS, National Notifiable Disease Surveillance System; EPS, Enhanced Pertussis Surveillance. All p values for comparisons were <0.0001.
†Unknown or missing responses were considered incomplete.
‡NNDSS completeness calculation excludes data from EPS area.
§Cough, paroxysms, whoop, and post-tussive vomiting

Main Article

Page created: August 12, 2015
Page updated: August 12, 2015
Page reviewed: August 12, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.